AstraZeneca’s Lynparza Safety Study in Japan: What the Latest Update Signals for AZN Investors - TipRanks6 hours ago • Google News
Is AstraZeneca (LSE:AZN) Still Attractive After Recent Share Price Pullback? - Yahoo Finance3 days ago • Google News